(Q31149036)

29 June 2017

title

Beta-blockers in the treatment of hypertension: new data, new directions (English)

1 reference

29 June 2017

4

Franz H Messerli

1 reference

29 June 2017

Michael A Weber

1

1 reference

29 June 2017

George L Bakris

series ordinal

2

1 reference

29 June 2017

Thomas D Giles

series ordinal

3

1 reference

29 June 2017

publication date

1 March 2008

1 reference

Journal of Clinical Hypertension

29 June 2017

published in

1 reference

29 June 2017

volume

10

1 reference

29 June 2017

issue

3

1 reference

29 June 2017

page(s)

234-238

1 reference

Beta blockade during and after myocardial infarction: an overview of the randomized trials

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2008.07843.X

Beta-blockers in congestive heart failure. A Bayesian meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2008.07843.X

Cardiovascular protection using beta-blockers: a critical review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2008.07843.X

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2008.07843.X

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2008.07843.X

Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2008.07843.X

Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2008.07843.X

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2008.07843.X

Effect of Antihypertensive Drugs on Insulin, Glucose, and Lipid Metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2008.07843.X

The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2008.07843.X

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2008.07843.X

Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2008.07843.X

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2008.07843.X

Nebivolol decreases oxidative stress in essential hypertensive patients and increases nitric oxide by reducing its oxidative inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2008.07843.X

Comparison of effects on systolic and diastolic left ventricular function of nebivolol versus atenolol in patients with uncomplicated essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2008.07843.X

The efficacy and tolerability of nebivolol in hypertensive African American patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2008.07843.X

The vasodilatory beta-blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2008.07843.X

Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2008.07843.X

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2008.07843.X

Comparative effects of nebivolol and metoprolol on oxidative stress, insulin resistance, plasma adiponectin and soluble P-selectin levels in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2008.07843.X

Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2008.07843.X

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2008.07843.X

Beta-blockers and progression of coronary atherosclerosis: pooled analysis of 4 intravascular ultrasonography trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2008.07843.X

New hypertension guidelines from the National Institute for Health and Clinical Excellence and the British Hypertension Society.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2008.07843.X

Are β-Blockers Efficacious as First-line Therapy for Hypertension in the Elderly?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1751-7176.2008.07843.X

10.1111/J.1751-7176.2008.07843.X

21 January 2018

Identifiers

DOI

1 reference

29 June 2017

1 reference